Published in Anticancer Res on August 01, 2013
Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. Arterioscler Thromb Vasc Biol (2014) 1.87
Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer. Sci Rep (2015) 1.55
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology (2015) 1.24
Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol (2014) 1.23
Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma. Oncotarget (2015) 1.22
LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer. Biochim Biophys Acta (2015) 1.21
Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs. Eur Heart J (2014) 1.20
Identification of novel long non-coding RNAs in clear cell renal cell carcinoma. Clin Epigenetics (2015) 1.19
Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res Notes (2013) 1.04
Circulating RNAs as new biomarkers for detecting pancreatic cancer. World J Gastroenterol (2015) 1.01
Epigenetics: an emerging player in gastric cancer. World J Gastroenterol (2014) 1.01
LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition. BMC Cancer (2014) 0.96
Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer. Oncotarget (2016) 0.95
The bright side of dark matter: lncRNAs in cancer. J Clin Invest (2016) 0.94
The fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review). Int J Oncol (2014) 0.93
The Clinical Relevance of Long Non-Coding RNAs in Cancer. Cancers (Basel) (2015) 0.92
Long non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translation. Am J Cancer Res (2015) 0.92
MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression. Dig Dis Sci (2015) 0.91
Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma. Int J Clin Exp Pathol (2015) 0.88
Circulating long non-coding RNAs in cancer: current status and future perspectives. Mol Cancer (2016) 0.88
Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma. Cancer Sci (2016) 0.88
The prognostic significance of HOTAIR for predicting clinical outcome in patients with digestive system tumors. J Cancer Res Clin Oncol (2015) 0.87
Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal Cancer. Front Genet (2016) 0.87
Liquid biopsy of gastric cancer patients: circulating tumor cells and cell-free nucleic acids. World J Gastroenterol (2014) 0.86
Emerging blood-based biomarkers for detection of gastric cancer. World J Gastroenterol (2015) 0.86
Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer. Drug Des Devel Ther (2015) 0.85
Could lncRNAs be the missing links in control of mesenchymal stem cell differentiation? J Cell Physiol (2015) 0.85
The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis. Oncotarget (2016) 0.85
The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids. J Cell Mol Med (2015) 0.85
Dysregulation of non-coding RNAs in gastric cancer. World J Gastroenterol (2015) 0.84
The Significance of Long Noncoding RNA H19 in Predicting Progression and Metastasis of Cancers: A Meta-Analysis. Biomed Res Int (2016) 0.83
Long noncoding RNAs in gastric cancer: functions and clinical applications. Onco Targets Ther (2016) 0.83
Long Noncoding RNA in Digestive Tract Cancers: Function, Mechanism, and Potential Biomarker. Oncologist (2015) 0.82
Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer. Medicine (Baltimore) (2016) 0.82
Emerging paradigms of long non-coding RNAs in gastrointestinal cancer. Am J Stem Cells (2014) 0.81
Comparison Analysis of Dysregulated LncRNA Profile in Mouse Plasma and Liver after Hepatic Ischemia/Reperfusion Injury. PLoS One (2015) 0.80
Expression of MALAT1 in the peripheral whole blood of patients with lung cancer. Biomed Rep (2015) 0.80
Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer. J Gastroenterol (2015) 0.80
lincRNA HOTAIR as a novel promoter of cancer progression. J Can Res Updates (2014) 0.80
Non-coding landscapes of colorectal cancer. World J Gastroenterol (2015) 0.80
Circulating biomarkers to monitor cancer progression and treatment. Comput Struct Biotechnol J (2016) 0.78
Clinical implication of long noncoding RNA 91H expression profile in osteosarcoma patients. Onco Targets Ther (2016) 0.78
Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer. Theranostics (2017) 0.78
Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review. World J Gastroenterol (2015) 0.78
Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics. Dis Markers (2016) 0.78
Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets? Gastroenterol Res Pract (2015) 0.78
The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis. Medicine (Baltimore) (2016) 0.77
Epigenetic modulation associated with carcinogenesis and prognosis of human gastric cancer. Oncol Lett (2017) 0.76
Novel insight into MALAT-1 in cancer: Therapeutic targets and clinical applications. Oncol Lett (2016) 0.76
Hunting for the ultimate liquid cancer biopsy - let the TEP dance begin. Cell Commun Signal (2016) 0.76
Metastasis-associated long noncoding RNAs in gastrointestinal cancer: Implications for novel biomarkers and therapeutic targets. World J Gastroenterol (2016) 0.75
Plasma long non-coding RNA MALAT1 is associated with distant metastasis in patients with epithelial ovarian cancer. Oncol Lett (2016) 0.75
Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer. Oncotarget (2016) 0.75
Long Noncoding RNAs as Biomarkers in Cancer. Dis Markers (2017) 0.75
Noncoding RNAs in gastric cancer: Research progress and prospects. World J Gastroenterol (2016) 0.75
Differentially expressed circulating LncRNAs and mRNA identified by microarray analysis in obese patients. Sci Rep (2016) 0.75
Plasma lncRNA GAS8-AS1 as a Potential Biomarker of Papillary Thyroid Carcinoma in Chinese Patients. Int J Endocrinol (2017) 0.75
Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinoma. Sci Rep (2017) 0.75
The decision criterion of histological mixed type in "T1/T2" gastric carcinoma--comparison between TNM classification and Japanese Classification of Gastric Cancer. J Surg Oncol (2011) 1.57
Blockade of chloride ion transport enhances the cytocidal effect of hypotonic solution in gastric cancer cells. J Surg Res (2011) 1.50
Subtotal gastrectomy for cancer located in the greater curvature of the middle stomach with prevention of the left gastric artery. Am J Surg (2002) 1.46
Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma. Carcinogenesis (2009) 1.46
Successful use of ketamine for intractable burning pain of HTLV-1-associated myelopathy. J Pain Symptom Manage (2005) 1.42
[Obstruction of an reinforced endotracheal tube due to dissection of internal tube wall during total intravenous anesthesia]. Masui (2003) 1.31
Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly(L-glutamic acid) backbone for inhibition of infection by influenza viruses. Glycobiology (2002) 1.24
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1. J Bone Miner Res (2004) 1.19
Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma. Expert Opin Biol Ther (2012) 1.17
Three-step esophagojejunal anastomosis with atraumatic anvil insertion technique after laparoscopic total gastrectomy. J Gastrointest Surg (2011) 1.16
Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach. Am J Surg (2004) 1.16
Malignant transformation of meningeal melanocytoma: a case report. Brain Tumor Pathol (2003) 1.14
The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells (2007) 1.14
Progression of remnant gastric cancer is associated with duration of follow-up following distal gastrectomy. World J Gastroenterol (2012) 1.12
Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma. Carcinogenesis (2010) 1.11
A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy. Mol Cancer (2009) 1.06
Time to death and pattern of death in recurrence following curative resection of gastric carcinoma: analysis based on depth of invasion. World J Surg (2004) 1.06
Function-preserving gastrectomy for early gastric cancer. Ann Surg Oncol (2013) 1.05
Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. Anticancer Res (2013) 1.05
Tissue engineering of small intestinal tissue using collagen sponge scaffolds seeded with smooth muscle cells. Tissue Eng (2006) 1.05
Surgical outcomes of gastrectomy for elderly patients with gastric cancer. World J Surg (2013) 1.04
Circulating microRNA in digestive tract cancers. Gastroenterology (2012) 1.04
Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer. Anticancer Res (2007) 1.03
Risk factors and management of postoperative bile leakage after hepatectomy without bilioenteric anastomosis. Dig Surg (2011) 1.03
Intracellular chloride regulates cell proliferation through the activation of stress-activated protein kinases in MKN28 human gastric cancer cells. J Cell Physiol (2010) 1.02
A combination-weighted Feldkamp-based reconstruction algorithm for cone-beam CT. Phys Med Biol (2006) 1.02
Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients. Gastric Cancer (2011) 1.02
XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma. Ann Surg Oncol (2012) 1.02
Design and synthesis of highly sensitive and selective fluorescein-derived magnesium fluorescent probes and application to intracellular 3D Mg2+ imaging. J Am Chem Soc (2004) 1.02
Non-bifurcating cervical carotid artery. J Clin Neurosci (2006) 1.02
Brainstem congestion caused by direct carotid-cavernous fistula--case report. Neurol Med Chir (Tokyo) (2003) 1.02
Chloride ions control the G1/S cell-cycle checkpoint by regulating the expression of p21 through a p53-independent pathway in human gastric cancer cells. Biochem Biophys Res Commun (2007) 1.02
Clinicopathologic characteristics and prognosis of synchronous multifocal gastric carcinomas. Am J Surg (2005) 1.01
Postoperative complications following gastrectomy for gastric cancer during the last decade. Hepatogastroenterology (2004) 1.01
Identification of a novel spiropiperidine opioid receptor-like 1 antagonist class by a focused library approach featuring 3D-pharmacophore similarity. J Med Chem (2006) 1.01
Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer. Gastric Cancer (2014) 1.01